Aspirin alleviates pulmonary fibrosis through PI3K/AKT/mTOR-mediated autophagy pathway
Experimental Gerontology · 2023
DOI: 10.1016/j.exger.2023.112085 ↗Kurz gefasst
Fachartikel in der Zeitschrift Experimental Gerontology, 2023. Verfasst von Jieting Peng und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Geriatrics, The Second Xiangya Hospital, Central South University, Changsha, Hunan 410011, China. Hauptthemen laut MEDLINE: Proto-Oncogene Proteins c-akt, Idiopathic Pulmonary Fibrosis. Die Arbeit wurde bisher 45-mal zitiert (Crossref) und nennt 35 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: National Natural Science Foundation of China, Natural Science Foundation of Hunan Province, Key Research and Development Program of Jiangxi Province.
Abstract (Originalsprache)
Idiopathic pulmonary fibrosis (IPF) is a chronic and irreversible lung disease with limited therapeutic options. Aspirin can alleviate liver, kidney, and cardiac fibrosis. However, its role in lung fibrosis is unclear. This study aims to investigate the effects of aspirin on lung fibroblast differentiation and pulmonary fibrosis. TGF-β1-induced human embryonic lung fibroblasts, IPF lung fibroblasts, and bleomycin-induced lung fibrosis mouse model were used in this study. The results showed that aspirin significantly decreased the expression of Collagen 1A1, Fibronectin, Alpha-smooth muscle actin, and equestosome1, and increased the ratio of light chain 3 beta II/I and the number of autophagosome in vivo and in vitro; reduced bleomycin-induced lung fibrosis. Aspirin also decreased the ratios of phosphorylated phosphatidylinositol 3 kinase (p-PI3K)/PI3K, protein kinase B (p-AKT)/AKT, and mechanistic target of rapamycin (p-mTOR)/mTOR in vitro. Autophagy inhibitor 3-methyladenine, bafilomycin-A1, and AKT activator SC-79 abrogated the effects of aspirin. These findings indicate that aspirin ameliorates pulmonary fibrosis through a PI3K/AKT/mTOR-dependent autophagy pathway.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Geriatrics, The Second Xiangya Hospital, Central South University, Changsha, Hunan 410011, China.
- Laboratory of Clinical Medicine, The Second Xiangya Hospital, Central South University, Changsha, Hunan 410011, China.
- Division of Pulmonary, Allergy, and Critical Care Medicine, Department of Medicine, University of Alabama at Birmingham, Birmingham, AL 35294, USA.
- Department of Geriatrics, The Second Xiangya Hospital, Central South University, Changsha, Hunan 410011, China. Electronic address: xiangyuzhang@csu.edu.cn.
Förderung
- National Natural Science Foundation of China
- Natural Science Foundation of Hunan Province
- Key Research and Development Program of Jiangxi Province
- Key Research and Development Program of Hunan Province of China
Zitieren
APA
Peng, J., Xiao, X., Li, S., Lyu, X., Gong, H., Tan, S., Dong, L., Sanders, Y. Y., & Zhang, X. (2023). Aspirin alleviates pulmonary fibrosis through PI3K/AKT/mTOR-mediated autophagy pathway. Experimental Gerontology. https://doi.org/10.1016/j.exger.2023.112085
Vancouver
Peng J, Xiao X, Li S, Lyu X, Gong H, Tan S, et al. Aspirin alleviates pulmonary fibrosis through PI3K/AKT/mTOR-mediated autophagy pathway. Experimental Gerontology. 2023. doi:10.1016/j.exger.2023.112085
BibTeX
@article{Peng2023,
author = {Peng, Jieting and Xiao, Xun and Li, Shizhen and Lyu, Xing and Gong, Hui and Tan, Shengyu and Dong, Lini and Sanders, Yan Y and Zhang, Xiangyu},
title = {Aspirin alleviates pulmonary fibrosis through PI3K/AKT/mTOR-mediated autophagy pathway},
journal = {Experimental Gerontology},
year = {2023},
doi = {10.1016/j.exger.2023.112085}
}
EUVIMED